IN2014MU00190A - - Google Patents
Info
- Publication number
- IN2014MU00190A IN2014MU00190A IN190MU2014A IN2014MU00190A IN 2014MU00190 A IN2014MU00190 A IN 2014MU00190A IN 190MU2014 A IN190MU2014 A IN 190MU2014A IN 2014MU00190 A IN2014MU00190 A IN 2014MU00190A
- Authority
- IN
- India
- Prior art keywords
- ticagrelor
- salts
- solid oral
- oral pharmaceutical
- pharmaceutical compositions
- Prior art date
Links
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000007787 solid Substances 0.000 abstract 3
- OEKWJQXRCDYSHL-FNOIDJSQSA-N ticagrelor Chemical compound C1([C@@H]2C[C@H]2NC=2N=C(N=C3N([C@H]4[C@@H]([C@H](O)[C@@H](OCCO)C4)O)N=NC3=2)SCCC)=CC=C(F)C(F)=C1 OEKWJQXRCDYSHL-FNOIDJSQSA-N 0.000 abstract 3
- 229960002528 ticagrelor Drugs 0.000 abstract 3
- 208000004476 Acute Coronary Syndrome Diseases 0.000 abstract 2
- 230000007211 cardiovascular event Effects 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000001732 thrombotic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2015/050426 WO2015110952A1 (en) | 2014-01-21 | 2015-01-20 | Solid oral pharmaceutical compositions comprising ticagrelor or salt thereof |
| IN190MU2014 IN2014MU00190A (enExample) | 2014-01-21 | 2015-01-20 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN190MU2014 IN2014MU00190A (enExample) | 2014-01-21 | 2015-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MU00190A true IN2014MU00190A (enExample) | 2015-08-28 |
Family
ID=54393487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN190MU2014 IN2014MU00190A (enExample) | 2014-01-21 | 2015-01-20 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2014MU00190A (enExample) |
-
2015
- 2015-01-20 IN IN190MU2014 patent/IN2014MU00190A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017501321A1 (en) | Oral care compositions and methods of use | |
| WO2013072932A3 (en) | Oral care compositions | |
| WO2015160843A8 (en) | Ion channel activators and methods of use | |
| NZ734233A (en) | Pharmaceutical compositions comprising meloxicam | |
| IN2013MU03583A (enExample) | ||
| PH12018500071A1 (en) | Plinabulin compositions | |
| EP3878445A3 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| IN2013MU00711A (enExample) | ||
| PH12015501783B1 (en) | Pharmaceutical compositions for the treatment of helicobacter pylori | |
| PH12015502082A1 (en) | Improved stability and potency of hemagglutinin | |
| WO2014203275A3 (en) | An improved process for the preparation of apixaban and intermediates thereof | |
| TN2015000267A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
| EP2611799A4 (en) | PHARMACEUTICAL COMPOSITIONS OF LINEZOLID | |
| MX2015012771A (es) | Procedimiento de tratamiento de la deficiencia de vitamina b12. | |
| PH12020500045A1 (en) | Novel composition of enzalutamide oral dosage form and method of manufacturing thereof | |
| IN2014MU00190A (enExample) | ||
| MX2021015441A (es) | Formas cristalinas de cabotegravir de sodio. | |
| IN2014KN02981A (enExample) | ||
| IN2014MU00188A (enExample) | ||
| IN2013MU03428A (enExample) | ||
| IN2014MU00189A (enExample) | ||
| IN2014MU00191A (enExample) | ||
| MX2018005134A (es) | Formulacion de factor viii (fviii). | |
| IN2013CH04314A (enExample) | ||
| WO2019151965A3 (en) | Solid oral pharmaceutical compositions comprising apixaban |